Filing Flows › Medtronic (MDT) › Q1 FY27 › vs Q1 FY26
Medtronic (MDT) Q1 FY27 vs Q1 FY26 (year over year)
Medtronic's revenue rose $1.2B (+14%) from $8.6B in Q1 FY26 to $9.8B in Q1 FY27. Operating margin 18.1% against 16.8% (+1.2 pts).
Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Operating margin | 18.1% | 16.8% | +1.2 pts |
| Net margin | 15.1% | 12.1% | +2.9 pts |
| Free cash flow margin | 13.2% | 6.8% | +6.4 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $9.8B | $8.6B | $1.2B | +14% |
| Operating profit | $1.8B | $1.4B | $319M | +22% |
| Costs & expenses | $8.0B | $7.1B | $859M | +12% |
| Pre-tax earnings | $1.8B | $1.3B | $467M | +36% |
| Cost of revenue | $3.4B | $3.0B | $415M | +14% |
| Research & development | $771M | $726M | $45.0M | +6% |
| SG&A | $3.2B | $2.8B | $392M | +14% |
| Other operating costs | $607M | $600M | $7.0M | +1% |
| Net earnings | $1.5B | $1.0B | $430M | +41% |
| Minority interests | $9.0M | $7.0M | $2.0M | +29% |
| Income tax | $289M | $255M | $34.0M | +13% |
| Depreciation & amortization | $729M | $748M | −$19.0M | -3% |
| Share-based compensation | $125M | $86.0M | $39.0M | +45% |
| Working capital & other | $531M | $786M | −$255M | -32% |
| Operating cash flow | $1.8B | $1.1B | $705M | +65% |
| Free Cash Flow (company-reported) | $1.3B | $584M | $706M | +121% |
| Itions to property, plant, and equipment | $503M | $504M | −$1.0M | -0.2% |
Questions
How much did Medtronic's revenue grow year over year in Q1 FY27?
Medtronic's revenue rose $1.2B (+14%) from $8.6B in Q1 FY26 to $9.8B in Q1 FY27. Operating margin 18.1% against 16.8% (+1.2 pts).